PMV Pharmaceuticals Inc (PMVP): Next-Year EPS Estimate 35.19%
As of 2026-11-12, PMV Pharmaceuticals Inc (PMVP) has a next-year EPS growth estimate of 35.19%. Featured in our EPS revision report on 2026-09-10.
On 2026-11-11, analyst consensus for PMVP's next-year EPS growth shifted from 27.81% to 35.19% — a positive change of 7.38 percentage points. The revised estimate has been sustained across 2 subsequent trading sessions. Current-year growth is projected at 8.78%.
What's Driving This
The primary structural driver
Generated 2026-11-06 from news as of 2026-11-06
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 35.19%
- EPS growth this year
- 8.78%
- EPS next quarter (est)
- -$0.27
- Last price
- $1.21
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-11-12 | 35.19% | 8.78% | -$0.27 | $1.21 |
| 2026-11-11 | 35.19% | 8.78% | -$0.27 | $1.26 |
| 2026-11-10 | 27.81% | 23.87% | -$0.25 | $1.22 |
| 2026-11-09 | 27.81% | 23.87% | -$0.34 | $1.25 |
| 2026-11-07 | 27.81% | 23.87% | -$0.34 | $1.26 |
| 2026-11-06 | 27.81% | 23.87% | -$0.34 | $1.26 |
| 2026-11-05 | 27.81% | 23.87% | -$0.34 | $1.27 |
| 2026-11-04 | 27.81% | 23.87% | -$0.34 | $1.33 |
| 2026-11-03 | 27.81% | 23.87% | -$0.34 | $1.38 |
| 2026-11-02 | 27.81% | 23.87% | -$0.34 | $1.37 |
| 2026-10-31 | 27.81% | 23.87% | -$0.34 | $1.31 |
| 2026-10-30 | 27.81% | 23.87% | -$0.34 | $1.31 |
| 2026-10-29 | 25.10% | 19.26% | -$0.34 | $1.35 |
| 2026-10-28 | 25.10% | 19.26% | -$0.34 | $1.38 |
| 2026-10-27 | 25.10% | 19.26% | -$0.34 | $1.25 |
| 2026-10-26 | 25.10% | 19.26% | -$0.34 | $1.13 |
| 2026-10-23 | 25.10% | 19.26% | -$0.34 | $1.27 |
| 2026-10-22 | 25.10% | 19.26% | -$0.34 | $1.30 |
| 2026-10-21 | 25.10% | 19.26% | -$0.34 | $1.36 |
| 2026-10-20 | 25.10% | 19.26% | -$0.34 | $1.39 |
| 2026-10-19 | 25.10% | 19.26% | -$0.34 | $1.25 |
| 2026-10-16 | 25.10% | 19.26% | -$0.34 | $1.21 |
| 2026-10-15 | 25.10% | 19.26% | -$0.34 | $1.29 |
| 2026-10-14 | 25.10% | 19.26% | -$0.34 | $1.24 |
| 2026-10-13 | 25.10% | 19.26% | -$0.34 | $1.35 |
| 2026-10-12 | 25.10% | 19.26% | -$0.34 | $1.41 |
| 2026-10-11 | 25.10% | 19.26% | -$0.34 | $1.52 |
| 2026-10-10 | 25.10% | 19.26% | -$0.34 | $1.52 |
| 2026-10-09 | 25.10% | 19.26% | -$0.34 | $1.52 |
| 2026-10-08 | 25.10% | 19.26% | -$0.34 | $1.49 |
Reports Featuring PMVP
Screen Performance
Aggregate stats across all 2145 tickers our top-EPS-revision screen has flagged over the past 225 days.
- Median return since detection
- -2.9%
- % of tickers in the green
- 43%
- Median return on winners
- +22.8%
- Large revisions captured
- 2246
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is PMV Pharmaceuticals Inc's next-year EPS growth estimate?▾
As of 2026-11-12, PMV Pharmaceuticals Inc (PMVP) has a next-year EPS growth estimate of 35.19%, based on analyst consensus.
When was the latest EPS estimate revision for PMVP?▾
The most recent revision occurred on 2026-11-11, when analysts adjusted the next-year EPS growth estimate from 27.81% to 35.19%.
What sector and industry does PMV Pharmaceuticals Inc belong to?▾
PMV Pharmaceuticals Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. PMVP appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. PMV Pharmaceuticals Inc (PMVP) appears here because it was detected by our daily top-EPS-revision-performer screen.